Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetyl Cysteine in Children With Drug-Resistant Epilepsy
NCT05485558Phase 2Completed
- Sponsor
- Tanta University
- Start
- Sep 2022
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acetylcysteine in epilepsy, sponsored by Tanta University. Started Sep 2022; status: completed.
02
Drugs
acetylcysteine
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT05485558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05485558.